 | • レポートコード：QFJ1-4974 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、経粘膜薬物送達システムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬物送達、経鼻薬物送達、直腸薬物送達、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・経粘膜薬物送達システムの市場動向 ・企業の競争状況、市場シェア ・経粘膜薬物送達システムの種類別市場規模と予測2016-2027（経口薬物送達、経鼻薬物送達、直腸薬物送達、その他） ・経粘膜薬物送達システムの用途別市場規模と予測2016-2027（病院、診療所、その他） ・経粘膜薬物送達システムの北米市場規模2016-2027（アメリカ、カナダ） ・経粘膜薬物送達システムの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・経粘膜薬物送達システムのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・経粘膜薬物送達システムの中南米市場規模2016-2027（メキシコ、ブラジル） ・経粘膜薬物送達システムの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（3M、Antares Pharma、Aveva Drug Delivery Systems、Corium International、Acrux Limited、ALZA Corporation、DURECT Corporation、Generex Biotechnology） ・結論 |
The transmucosal route includes oral, nasal, vaginal, and urethral and presents a challenge in the field of novel drug delivery technology. The transmucosal membranes are relatively permeable, have a rich blood flow and hence allow the rapid uptake of a drug into systemic circulation to avoid first pass metabolism.
Market Analysis and Insights: Global Transmucosal Drug Delivery Systems Market
The global Transmucosal Drug Delivery Systems market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transmucosal Drug Delivery Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transmucosal Drug Delivery Systems market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transmucosal Drug Delivery Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transmucosal Drug Delivery Systems market.
Global Transmucosal Drug Delivery Systems Scope and Market Size
Transmucosal Drug Delivery Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transmucosal Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral Drug Delivery
Nasal Drug Delivery
Rectal Drug Delivery
Other
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
Acrux Limited
ALZA Corporation
DURECT Corporation
Generex Biotechnology
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transmucosal Drug Delivery Systems Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Drug Delivery
1.2.3 Nasal Drug Delivery
1.2.4 Rectal Drug Delivery
1.2.5 Other
1.3 Market by Application
1.3.1 Global Transmucosal Drug Delivery Systems Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Transmucosal Drug Delivery Systems Market Perspective (2016-2027)
2.2 Transmucosal Drug Delivery Systems Growth Trends by Regions
2.2.1 Transmucosal Drug Delivery Systems Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Transmucosal Drug Delivery Systems Historic Market Share by Regions (2016-2021)
2.2.3 Transmucosal Drug Delivery Systems Forecasted Market Size by Regions (2022-2027)
2.3 Transmucosal Drug Delivery Systems Industry Dynamic
2.3.1 Transmucosal Drug Delivery Systems Market Trends
2.3.2 Transmucosal Drug Delivery Systems Market Drivers
2.3.3 Transmucosal Drug Delivery Systems Market Challenges
2.3.4 Transmucosal Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transmucosal Drug Delivery Systems Players by Revenue
3.1.1 Global Top Transmucosal Drug Delivery Systems Players by Revenue (2016-2021)
3.1.2 Global Transmucosal Drug Delivery Systems Revenue Market Share by Players (2016-2021)
3.2 Global Transmucosal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Transmucosal Drug Delivery Systems Revenue
3.4 Global Transmucosal Drug Delivery Systems Market Concentration Ratio
3.4.1 Global Transmucosal Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transmucosal Drug Delivery Systems Revenue in 2020
3.5 Transmucosal Drug Delivery Systems Key Players Head office and Area Served
3.6 Key Players Transmucosal Drug Delivery Systems Product Solution and Service
3.7 Date of Enter into Transmucosal Drug Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transmucosal Drug Delivery Systems Breakdown Data by Type
4.1 Global Transmucosal Drug Delivery Systems Historic Market Size by Type (2016-2021)
4.2 Global Transmucosal Drug Delivery Systems Forecasted Market Size by Type (2022-2027)
5 Transmucosal Drug Delivery Systems Breakdown Data by Application
5.1 Global Transmucosal Drug Delivery Systems Historic Market Size by Application (2016-2021)
5.2 Global Transmucosal Drug Delivery Systems Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Transmucosal Drug Delivery Systems Market Size (2016-2027)
6.2 North America Transmucosal Drug Delivery Systems Market Size by Type
6.2.1 North America Transmucosal Drug Delivery Systems Market Size by Type (2016-2021)
6.2.2 North America Transmucosal Drug Delivery Systems Market Size by Type (2022-2027)
6.2.3 North America Transmucosal Drug Delivery Systems Market Size by Type (2016-2027)
6.3 North America Transmucosal Drug Delivery Systems Market Size by Application
6.3.1 North America Transmucosal Drug Delivery Systems Market Size by Application (2016-2021)
6.3.2 North America Transmucosal Drug Delivery Systems Market Size by Application (2022-2027)
6.3.3 North America Transmucosal Drug Delivery Systems Market Size by Application (2016-2027)
6.4 North America Transmucosal Drug Delivery Systems Market Size by Country
6.4.1 North America Transmucosal Drug Delivery Systems Market Size by Country (2016-2021)
6.4.2 North America Transmucosal Drug Delivery Systems Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Transmucosal Drug Delivery Systems Market Size (2016-2027)
7.2 Europe Transmucosal Drug Delivery Systems Market Size by Type
7.2.1 Europe Transmucosal Drug Delivery Systems Market Size by Type (2016-2021)
7.2.2 Europe Transmucosal Drug Delivery Systems Market Size by Type (2022-2027)
7.2.3 Europe Transmucosal Drug Delivery Systems Market Size by Type (2016-2027)
7.3 Europe Transmucosal Drug Delivery Systems Market Size by Application
7.3.1 Europe Transmucosal Drug Delivery Systems Market Size by Application (2016-2021)
7.3.2 Europe Transmucosal Drug Delivery Systems Market Size by Application (2022-2027)
7.3.3 Europe Transmucosal Drug Delivery Systems Market Size by Application (2016-2027)
7.4 Europe Transmucosal Drug Delivery Systems Market Size by Country
7.4.1 Europe Transmucosal Drug Delivery Systems Market Size by Country (2016-2021)
7.4.2 Europe Transmucosal Drug Delivery Systems Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Transmucosal Drug Delivery Systems Market Size (2016-2027)
8.2 Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Type
8.2.1 Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Type (2016-2027)
8.3 Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Application
8.3.1 Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Application (2016-2027)
8.4 Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Region
8.4.1 Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Transmucosal Drug Delivery Systems Market Size (2016-2027)
9.2 Latin America Transmucosal Drug Delivery Systems Market Size by Type
9.2.1 Latin America Transmucosal Drug Delivery Systems Market Size by Type (2016-2021)
9.2.2 Latin America Transmucosal Drug Delivery Systems Market Size by Type (2022-2027)
9.2.3 Latin America Transmucosal Drug Delivery Systems Market Size by Type (2016-2027)
9.3 Latin America Transmucosal Drug Delivery Systems Market Size by Application
9.3.1 Latin America Transmucosal Drug Delivery Systems Market Size by Application (2016-2021)
9.3.2 Latin America Transmucosal Drug Delivery Systems Market Size by Application (2022-2027)
9.3.3 Latin America Transmucosal Drug Delivery Systems Market Size by Application (2016-2027)
9.4 Latin America Transmucosal Drug Delivery Systems Market Size by Country
9.4.1 Latin America Transmucosal Drug Delivery Systems Market Size by Country (2016-2021)
9.4.2 Latin America Transmucosal Drug Delivery Systems Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transmucosal Drug Delivery Systems Market Size (2016-2027)
10.2 Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Type
10.2.1 Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Type (2016-2027)
10.3 Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Application
10.3.1 Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Application (2016-2027)
10.4 Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Country
10.4.1 Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 3M
11.1.1 3M Company Details
11.1.2 3M Business Overview
11.1.3 3M Transmucosal Drug Delivery Systems Introduction
11.1.4 3M Revenue in Transmucosal Drug Delivery Systems Business (2016-2021)
11.1.5 3M Recent Development
11.2 Antares Pharma
11.2.1 Antares Pharma Company Details
11.2.2 Antares Pharma Business Overview
11.2.3 Antares Pharma Transmucosal Drug Delivery Systems Introduction
11.2.4 Antares Pharma Revenue in Transmucosal Drug Delivery Systems Business (2016-2021)
11.2.5 Antares Pharma Recent Development
11.3 Aveva Drug Delivery Systems
11.3.1 Aveva Drug Delivery Systems Company Details
11.3.2 Aveva Drug Delivery Systems Business Overview
11.3.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Systems Introduction
11.3.4 Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Systems Business (2016-2021)
11.3.5 Aveva Drug Delivery Systems Recent Development
11.4 Corium International
11.4.1 Corium International Company Details
11.4.2 Corium International Business Overview
11.4.3 Corium International Transmucosal Drug Delivery Systems Introduction
11.4.4 Corium International Revenue in Transmucosal Drug Delivery Systems Business (2016-2021)
11.4.5 Corium International Recent Development
11.5 Acrux Limited
11.5.1 Acrux Limited Company Details
11.5.2 Acrux Limited Business Overview
11.5.3 Acrux Limited Transmucosal Drug Delivery Systems Introduction
11.5.4 Acrux Limited Revenue in Transmucosal Drug Delivery Systems Business (2016-2021)
11.5.5 Acrux Limited Recent Development
11.6 ALZA Corporation
11.6.1 ALZA Corporation Company Details
11.6.2 ALZA Corporation Business Overview
11.6.3 ALZA Corporation Transmucosal Drug Delivery Systems Introduction
11.6.4 ALZA Corporation Revenue in Transmucosal Drug Delivery Systems Business (2016-2021)
11.6.5 ALZA Corporation Recent Development
11.7 DURECT Corporation
11.7.1 DURECT Corporation Company Details
11.7.2 DURECT Corporation Business Overview
11.7.3 DURECT Corporation Transmucosal Drug Delivery Systems Introduction
11.7.4 DURECT Corporation Revenue in Transmucosal Drug Delivery Systems Business (2016-2021)
11.7.5 DURECT Corporation Recent Development
11.8 Generex Biotechnology
11.8.1 Generex Biotechnology Company Details
11.8.2 Generex Biotechnology Business Overview
11.8.3 Generex Biotechnology Transmucosal Drug Delivery Systems Introduction
11.8.4 Generex Biotechnology Revenue in Transmucosal Drug Delivery Systems Business (2016-2021)
11.8.5 Generex Biotechnology Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Transmucosal Drug Delivery Systems Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Drug Delivery
Table 3. Key Players of Nasal Drug Delivery
Table 4. Key Players of Rectal Drug Delivery
Table 5. Key Players of Other
Table 6. Global Transmucosal Drug Delivery Systems Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Transmucosal Drug Delivery Systems Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Transmucosal Drug Delivery Systems Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Transmucosal Drug Delivery Systems Market Share by Regions (2016-2021)
Table 10. Global Transmucosal Drug Delivery Systems Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Transmucosal Drug Delivery Systems Market Share by Regions (2022-2027)
Table 12. Transmucosal Drug Delivery Systems Market Trends
Table 13. Transmucosal Drug Delivery Systems Market Drivers
Table 14. Transmucosal Drug Delivery Systems Market Challenges
Table 15. Transmucosal Drug Delivery Systems Market Restraints
Table 16. Global Transmucosal Drug Delivery Systems Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Transmucosal Drug Delivery Systems Market Share by Players (2016-2021)
Table 18. Global Top Transmucosal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transmucosal Drug Delivery Systems as of 2020)
Table 19. Ranking of Global Top Transmucosal Drug Delivery Systems Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Transmucosal Drug Delivery Systems Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Transmucosal Drug Delivery Systems Product Solution and Service
Table 23. Date of Enter into Transmucosal Drug Delivery Systems Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Transmucosal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Transmucosal Drug Delivery Systems Revenue Market Share by Type (2016-2021)
Table 27. Global Transmucosal Drug Delivery Systems Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Transmucosal Drug Delivery Systems Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Transmucosal Drug Delivery Systems Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Transmucosal Drug Delivery Systems Revenue Market Share by Application (2016-2021)
Table 31. Global Transmucosal Drug Delivery Systems Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Transmucosal Drug Delivery Systems Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Transmucosal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Transmucosal Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Transmucosal Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Transmucosal Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Transmucosal Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Transmucosal Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Transmucosal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Transmucosal Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Transmucosal Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Transmucosal Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Transmucosal Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Transmucosal Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Transmucosal Drug Delivery Systems Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Transmucosal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Transmucosal Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Transmucosal Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Transmucosal Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Transmucosal Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Transmucosal Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Transmucosal Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
Table 63. 3M Company Details
Table 64. 3M Business Overview
Table 65. 3M Transmucosal Drug Delivery Systems Product
Table 66. 3M Revenue in Transmucosal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 67. 3M Recent Development
Table 68. Antares Pharma Company Details
Table 69. Antares Pharma Business Overview
Table 70. Antares Pharma Transmucosal Drug Delivery Systems Product
Table 71. Antares Pharma Revenue in Transmucosal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 72. Antares Pharma Recent Development
Table 73. Aveva Drug Delivery Systems Company Details
Table 74. Aveva Drug Delivery Systems Business Overview
Table 75. Aveva Drug Delivery Systems Transmucosal Drug Delivery Systems Product
Table 76. Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 77. Aveva Drug Delivery Systems Recent Development
Table 78. Corium International Company Details
Table 79. Corium International Business Overview
Table 80. Corium International Transmucosal Drug Delivery Systems Product
Table 81. Corium International Revenue in Transmucosal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 82. Corium International Recent Development
Table 83. Acrux Limited Company Details
Table 84. Acrux Limited Business Overview
Table 85. Acrux Limited Transmucosal Drug Delivery Systems Product
Table 86. Acrux Limited Revenue in Transmucosal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 87. Acrux Limited Recent Development
Table 88. ALZA Corporation Company Details
Table 89. ALZA Corporation Business Overview
Table 90. ALZA Corporation Transmucosal Drug Delivery Systems Product
Table 91. ALZA Corporation Revenue in Transmucosal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 92. ALZA Corporation Recent Development
Table 93. DURECT Corporation Company Details
Table 94. DURECT Corporation Business Overview
Table 95. DURECT Corporation Transmucosal Drug Delivery Systems Product
Table 96. DURECT Corporation Revenue in Transmucosal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 97. DURECT Corporation Recent Development
Table 98. Generex Biotechnology Company Details
Table 99. Generex Biotechnology Business Overview
Table 100. Generex Biotechnology Revenue in Transmucosal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 101. Generex Biotechnology Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transmucosal Drug Delivery Systems Market Share by Type: 2020 VS 2027
Figure 2. Oral Drug Delivery Features
Figure 3. Nasal Drug Delivery Features
Figure 4. Rectal Drug Delivery Features
Figure 5. Other Features
Figure 6. Global Transmucosal Drug Delivery Systems Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Transmucosal Drug Delivery Systems Report Years Considered
Figure 11. Global Transmucosal Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Transmucosal Drug Delivery Systems Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Transmucosal Drug Delivery Systems Market Share by Regions: 2020 VS 2027
Figure 14. Global Transmucosal Drug Delivery Systems Market Share by Regions (2022-2027)
Figure 15. Global Transmucosal Drug Delivery Systems Market Share by Players in 2020
Figure 16. Global Top Transmucosal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transmucosal Drug Delivery Systems as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Transmucosal Drug Delivery Systems Revenue in 2020
Figure 18. Global Transmucosal Drug Delivery Systems Revenue Market Share by Type (2016-2021)
Figure 19. Global Transmucosal Drug Delivery Systems Revenue Market Share by Type (2022-2027)
Figure 20. North America Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Transmucosal Drug Delivery Systems Market Share by Type (2016-2027)
Figure 22. North America Transmucosal Drug Delivery Systems Market Share by Application (2016-2027)
Figure 23. North America Transmucosal Drug Delivery Systems Market Share by Country (2016-2027)
Figure 24. United States Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Transmucosal Drug Delivery Systems Market Share by Type (2016-2027)
Figure 28. Europe Transmucosal Drug Delivery Systems Market Share by Application (2016-2027)
Figure 29. Europe Transmucosal Drug Delivery Systems Market Share by Country (2016-2027)
Figure 30. Germany Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Transmucosal Drug Delivery Systems Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Transmucosal Drug Delivery Systems Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Transmucosal Drug Delivery Systems Market Share by Region (2016-2027)
Figure 40. China Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Transmucosal Drug Delivery Systems Market Share by Type (2016-2027)
Figure 48. Latin America Transmucosal Drug Delivery Systems Market Share by Application (2016-2027)
Figure 49. Latin America Transmucosal Drug Delivery Systems Market Share by Country (2016-2027)
Figure 50. Mexico Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Transmucosal Drug Delivery Systems Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Transmucosal Drug Delivery Systems Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Transmucosal Drug Delivery Systems Market Share by Country (2016-2027)
Figure 56. Turkey Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Transmucosal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. 3M Revenue Growth Rate in Transmucosal Drug Delivery Systems Business (2016-2021)
Figure 60. Antares Pharma Revenue Growth Rate in Transmucosal Drug Delivery Systems Business (2016-2021)
Figure 61. Aveva Drug Delivery Systems Revenue Growth Rate in Transmucosal Drug Delivery Systems Business (2016-2021)
Figure 62. Corium International Revenue Growth Rate in Transmucosal Drug Delivery Systems Business (2016-2021)
Figure 63. Acrux Limited Revenue Growth Rate in Transmucosal Drug Delivery Systems Business (2016-2021)
Figure 64. ALZA Corporation Revenue Growth Rate in Transmucosal Drug Delivery Systems Business (2016-2021)
Figure 65. DURECT Corporation Revenue Growth Rate in Transmucosal Drug Delivery Systems Business (2016-2021)
Figure 66. Generex Biotechnology Revenue Growth Rate in Transmucosal Drug Delivery Systems Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の経粘膜ドラッグデリバリー装置産業調査2019-2025 Transmucosal drug delivery devices are commonly used to deliver drugs locally through the mucous membrane.The Transmucosal Drug Delivery Devices market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2…- 世界の経粘膜ドラッグデリバリー装置産業調査2019-2025 Transmucosal drug delivery devices are commonly used to deliver drugs locally through the mucous membrane.The Transmucosal Drug Delivery Devices market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2…
- 世界の経皮薬物送達システム市場規模・現状・予測（2021年-2027年） Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other type…
- 世界の小分子ドラッグデリバリー市場規模・現状・予測（2021年-2027年） The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their size, easy convertibility to oral form and cost affectivity. The discovery of novel small molecule entities …
- 世界のドラッグデリバリーアクロス血液脳関門市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Delivery Across Blood Brain Barrier Market The global Drug Delivery Across Blood Brain Barrier market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…